Endocrinology And Nephrology And Chu Of Quebec Research Center

Québec, Canada

Endocrinology And Nephrology And Chu Of Quebec Research Center

Québec, Canada

Time filter

Source Type

PubMed | King Abdulaziz University, University of East Anglia, Laval University and Endocrinology And Nephrology And Chu Of Quebec Research Center
Type: Journal Article | Journal: Journal of lipid research | Year: 2016

Studies have shown a large interindividual variability in plasma TG response to long-chain n-3 PUFA supplementation, which may likely be attributable to genetic variability within the populations studied. The objective is to compare the frequency of SNPs in a genome-wide association study between responders (reduction in plasma TG levels 0.01 mM) and nonresponders (increase in plasma TG of 0 mM) to supplementation. Genomic DNA from 141 subjects who completed a 2-week run-in period followed by 6-week supplementation with 5 g of fish oil daily (1.9-2.2 g EPA and 1.1 g DHA daily) were genotyped on Illumina HumanOmni-5-QuadBeadChip. Thirteen loci had frequency differences between responders and nonresponders (P < 1 10(-5)), including SNPs in or near IQCJ-SCHIP1, MYB, NELL1, NXPH1, PHF17, and SLIT2 genes. A genetic risk score (GRS) was constructed by summing the number of risk alleles. This GRS explained 21.53% of the variation in TG response to n-3 PUFA supplementation when adjusted for age, sex, and BMI (P = 0.0002). Using Fish Oil Intervention and Genotype as a replication cohort, the GRS was able to explain 2% of variation in TG response when adjusted. In conclusion, subjects who decrease their plasma TG levels following n-3 PUFA supplementation may have a different genetic profile than individuals who do not respond.

Loading Endocrinology And Nephrology And Chu Of Quebec Research Center collaborators
Loading Endocrinology And Nephrology And Chu Of Quebec Research Center collaborators